IPCALAB — Ipca Laboratories Share News
0.000.00%
Last trade - 00:00- IN₹410.57bn
- IN₹421.10bn
- IN₹96.46bn
Refinitiv Newscasts - Asia Insight: Indian stocks rise in edgy Asian markets
India's Lyka Labs rises as bigger rival IPCA plans to buy stake
Brief: IPCA Labs Approves Acquisition Of 26.574% Stake In Lyka Labs Limited
Brief: IPCA Laboratories To Consider Interim Dividend And Sub-Division Of Shares
WHO-led trial to study three anti-inflammatory drugs for COVID-19 patients (updated)
WHO-led trial to study three anti-inflammatory drugs for COVID-19 patients (updated)
WHO-led trial to study three anti-inflammatory drugs for COVID-19 patients
Brief: India's IPCA Laboratories June-Quarter Consol Net Profit Falls
Brief: IPCA Laboratories Buys Further 13.09% Stake Of Trophic Wellness
Brief: India's IPCA Laboratories March-Quarter Consol Net Profit Rises
Factbox: Indo-China trade relations in focus as border face-off intensifies
Brief: IPCA Labs Says FDA Removed Exemption From Import Alert For Hydroxychloroquine Sulphate
Brief: IPCA Laboratories Says US FDA Communicated Chloroquine Phosphate Drug Product Is No Longer In Shortage
Brief: India's IPCA Laboratories March-Qtr Consol Net Profit Slips
India lifts export ban on Trump-touted drug hydroxychloroquine
India set to ship drug sought by Trump for coronavirus
Brief: India's IPCA Laboratories Dec Quarter Consol Profit Rises
Brief: IPCA Laboratories Says NCLT Approved Resolution Plan For Noble Explochem Ltd
Brief: IPCA Labs Gets U.S. FDA Inspection Classification Of OAI For Silvassa Facility